(Q36354082)

13 August 2017

Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection (English)

1 reference

13 August 2017

Maury CP

1

1 reference

PMCID

2188737

13 August 2017

Teppo AM

series ordinal

2

1 reference

PMCID

2188737

13 August 2017

language of work or name

English

0 references

publication date

1 October 1987

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

166

1 reference

13 August 2017

1132-1137

1 reference

13 August 2017

4

1 reference

Interleukin 2: Biology and biochemistry

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Shock and tissue injury induced by recombinant human cachectin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Tumour necrosis factor--an overview

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Cachectin: more than a tumor necrosis factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Raised serum levels of tumour necrosis factor in parasitic infections.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2188737

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

22 September 2018

1 reference

12 December 2020

Monitoring of human renal allograft rejection with fine-needle aspiration cytology.

1 reference

12 December 2020

Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2

1 reference

12 December 2020

A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia

1 reference

12 December 2020

An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDw18-dependent mechanism

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.166.4.1132

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

PMCID

2188737